Latest

neuropharmacology

·October 11, 2024·6 min read

Skin Pigmentation May Influence Drug Response

A new study highlights that skin pigmentation can influence how quickly medications reach their intended targets, with melanin potentially binding to certain drugs and slowing their efficacy. Researchers argue that this overlooked factor in drug testing could lead to varied drug responses across skin tones, impacting drug safety and dosing. Current FDA guidelines lack provisions addressing pigmentation’s effects on drug interactions, raising concerns for inclusivity in treatment efficacy.

Featured Neuroscience

·October 7, 2024·8 min read

How Conscious Thought Fades Under Anesthesia

A new study has shown that conscious thought relies on synchronized brain rhythms to maintain communication between sensory and cognitive brain regions. Under general anesthesia, this rhythm-based communication breaks down, disrupting the brain's ability to detect and process surprising stimuli.

Featured Neurology Neuroscience

·October 6, 2024·5 min read

Study Finds Wegovy Reduces COVID-19 Death Risk by One-Third

A new trial reveals that weekly injections of the weight-loss drug Wegovy (semaglutide) lowered the risk of death from COVID-19 by about a third and reduced overall mortality by 19%. The study followed more than 17,000 participants with heart disease and obesity, showing that Wegovy decreased the likelihood of death from cardiovascular disease by 15% and other causes by 23%.

Featured Neurology Neuroscience

·October 5, 2024·5 min read

New Molecule Offers Hope for Parkinson’s by Outperforming L-Dopa

A new study has discovered that ophthalmic acid, a molecule in the brain, acts like a neurotransmitter to regulate motor function, similar to dopamine. In Parkinson’s mouse models, this molecule improved movement for over 20 hours—far longer than the effects of the current treatment, L-dopa.

Featured Neuroscience

·October 4, 2024·5 min read

New Molecule Mimics Exercise and Fasting Effects

Researchers have developed a molecule called LaKe that mimics the metabolic effects of strenuous exercise and fasting. This molecule increases lactate and ketone levels in the body, providing similar benefits to running 10 kilometers on an empty stomach, without physical exertion or dietary changes.

Featured Neurology Neuroscience

·October 3, 2024·6 min read

Dual-Targeting Drug Halts Tau Accumulation in Alzheimer’s

Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in Alzheimer's disease. This peptide inhibitor, RI-AG03, effectively prevents Tau buildup in lab studies and fruit flies, offering hope for new Alzheimer's treatments.

Featured Neurology Neuroscience Pain

·October 3, 2024·4 min read

Chronic Pain Patients Favor Cannabis Legalization

A study found that 71% of adults with chronic pain support federal legalization of medical cannabis, compared to 59% of physicians. The research highlights a gap in attitudes toward cannabis policies between patients and doctors, especially regarding insurance coverage for cannabis treatments.

Featured Neurology Neuroscience Psychology

·October 2, 2024·4 min read

Cannabis Pill Reduces Agitation in Alzheimer’s Patients by 30%

A new study reveals that dronabinol, a synthetic form of THC, can reduce agitation in Alzheimer’s patients by 30%. Unlike current medications, dronabinol showed fewer side effects, such as delirium or seizures, making it a safer alternative.

Featured Neurology Neuroscience

·October 2, 2024·4 min read

Personalized Immune Therapy Offers Hope for MS Patients

A new study explores the use of tolerogenic dendritic cells (tolDCs) to restore immune balance in multiple sclerosis (MS) patients without compromising their immune system. The research reveals that MS patients’ immune cells have a pro-inflammatory signature, even after being modified for therapy.

Featured Neurology Neuroscience

·October 2, 2024·4 min read

Safer Epilepsy Treatment for Pregnant Women with Drug Combo

Rapamycin could counteract the harmful effects of Sodium Valproate, a common epilepsy medication, on fetal spinal cord development. Sodium Valproate is widely prescribed but poses risks during pregnancy, causing spinal malformations in fetuses.

Featured Genetics Neuroscience

·September 26, 2024·5 min read

Gut Microbiome and Aspirin May Reverse Hormonal Issues

Researchers found that mutations in the Sox3 gene cause hypopituitarism, a condition where the pituitary gland produces insufficient hormones, leading to growth issues and infertility. In a study on mice, they discovered that Sox3 mutations affect brain cells called NG2 glia, which are essential for hormone production.

Featured Neurology Neuroscience

·September 25, 2024·3 min read

Alzheimer’s Drug Faces Scrutiny Over Safety, Efficacy Concerns

The FDA-approved Alzheimer’s drug donanemab is under scrutiny due to concerns about its effectiveness and safety, according to an investigation. The study highlights multiple patient deaths during trials, design flaws, and the financial ties of panelists who recommended the drug's approval.

1 … 12 13 14 15 16 … 85

neuropharmacology

Skin Pigmentation May Influence Drug Response

How Conscious Thought Fades Under Anesthesia

Study Finds Wegovy Reduces COVID-19 Death Risk by One-Third

New Molecule Offers Hope for Parkinson’s by Outperforming L-Dopa

New Molecule Mimics Exercise and Fasting Effects

Dual-Targeting Drug Halts Tau Accumulation in Alzheimer’s

Chronic Pain Patients Favor Cannabis Legalization

Cannabis Pill Reduces Agitation in Alzheimer’s Patients by 30%

Personalized Immune Therapy Offers Hope for MS Patients

Safer Epilepsy Treatment for Pregnant Women with Drug Combo

Gut Microbiome and Aspirin May Reverse Hormonal Issues

Alzheimer’s Drug Faces Scrutiny Over Safety, Efficacy Concerns

Glioblastoma’s Chaos Follows Predictable Rules

One Autism Mutation Collapses the Whole Gene Network

Why Bitter Coffee Starts to Taste So Good to Your Brain

Omega-3 DHA Eases Autism Behaviors by Calming Inflammation

Subscribe